D52/100

Is Insulet Corporation (PODD) a risky stock?

Sector: Health Care Price: $165.33 Composite: 52/100

As of July 27, 2026, Clavix grades Insulet Corporation (PODD) D for risk, a composite score of 52 out of 100 on an A+ to F scale, which puts PODD in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 27, 2026. Clavix regrades every trading day.

PODD price, last 3 months

PODD's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.

$163.26 ▼ 13.9% · 3 months
Apr 24, 2026Jul 24, 2026

The five risk dimensions behind PODD's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how PODD scores on each, as of July 27, 2026.

Financial healthbalance sheet, margins, cash flow
82
News sentimentscored, sourced recent coverage
21
Macro exposuresensitivity to rates, dollar, oil
61
Sector resiliencestrength vs the broad market
64
Price stabilitydrawdown and volatility
34

What's moving PODD's risk right now

Company-specific signals Clavix flags behind PODD's current grade, drawn from recent news and filings as of July 27, 2026.

Regulatory · raising risk

The reminder signals ongoing litigation risk for PODD, which could pressure the stock, increase legal expenses, and potentially lead to settlements or damages that affect sharehol…

Recent PODD news

The latest headlines Clavix ingested for Insulet Corporation, newest first. These feed the news-sentiment dimension of PODD's grade.

What a D grade means

On the Clavix A+ to F scale, PODD's composite of 52 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell PODD or any security. Grades are risk indicators, not predictions of return. Data may be delayed.